Terms: = Ovarian cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
27 results:
1. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract] [Full Text] [Related]
2. Deep epigastric lymph nodes implication in patients' recurrence pattern after cytoreductive surgery in ovarian peritoneal metastases.
El Asmar A; Vouche M; Pop F; Polastro L; Chintinne M; Veys I; Donckier V; Liberale G
Eur J Surg Oncol; 2023 Sep; 49(9):106911. PubMed ID: 37149402
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
4. [Establishment and application of a nomogram model for prognostic risk prediction in patients with epithelial ovarian cancer].
Li Z; Cai XW; Yan P; Zhou D; He MM; Deng L; Wang YZ; Liang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):190-197. PubMed ID: 35385956
[No Abstract] [Full Text] [Related]
5. Leptin Protein Expression and Promoter Methylation in ovarian cancer: A Strong Prognostic Value with Theranostic Promises.
Assidi M; Yahya FM; Al-Zahrani MH; Elkhatib R; Zari A; Elaimi A; Al-Maghrabi J; Dallol A; Buhmeida A; Abu-Elmagd M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884678
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic value of the lymph node ratio in patients with stage IIIC ovarian cancer treated with preoperative chemotherapy.
Hai J; Feng L; Yang J; Niu X; Jiang H
Ann Palliat Med; 2021 Nov; 10(11):11504-11511. PubMed ID: 34872275
[TBL] [Abstract] [Full Text] [Related]
7. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
[No Abstract] [Full Text] [Related]
8. Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique.
Kim SI; Yoon S; Kim TM; Cho JY; Chung HH; Song YS
Gynecol Oncol; 2021 Jul; 162(1):72-79. PubMed ID: 33994146
[TBL] [Abstract] [Full Text] [Related]
9. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
[TBL] [Abstract] [Full Text] [Related]
10. [The role and mechanism of human trophoblastic cell surface antigen 2 in the invasion and metastasis of ovarian cancer].
Liu MB; Shi XF; Liu K; Song WY; Wang L; Wu HY; Wu GY
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):299-305. PubMed ID: 33752309
[No Abstract] [Full Text] [Related]
11. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
Li S; Zhu Z
J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
[TBL] [Abstract] [Full Text] [Related]
12. A Five-microRNA Signature as Risk Stratification System in Uterine Corpus Endometrial Carcinoma.
Chen Z; Huang X; Lv Y; Fang Y; Pan L; Gan Z; Huang Z; Wei W
Comb Chem High Throughput Screen; 2021; 24(2):187-194. PubMed ID: 32748742
[TBL] [Abstract] [Full Text] [Related]
13. Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study.
Park SJ; Kim J; Kim HS; Lee JW; Chang HK; Lee KH; Kim DY; Kim S; Chang SJ; Han SS; Park SY; Shim SH
J Gynecol Oncol; 2020 Mar; 31(2):e15. PubMed ID: 31912673
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic factors in Krukenberg tumor.
Lionetti R; De Luca M; Travaglino A; Raffone A; Saccone G; Di Cicco A; Insabato L; Mascolo M; D'Armiento M; Zullo F; Corcione F
Arch Gynecol Obstet; 2019 Nov; 300(5):1155-1165. PubMed ID: 31542818
[TBL] [Abstract] [Full Text] [Related]
15. DAAM1-mediated migration and invasion of ovarian cancer cells are suppressed by miR-208a-5p.
Mei J; Huang Y; Hao L; Liu Y; Yan T; Qiu T; Xu R; Xu B; Xiao Z; Jiang X; Hu K; Zhu Y
Pathol Res Pract; 2019 Jul; 215(7):152452. PubMed ID: 31104928
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.
Lee YJ; Chung YS; Lee JY; Nam EJ; Kim SW; Kim S; Kim YT
Eur J Surg Oncol; 2019 Apr; 45(4):644-649. PubMed ID: 30337203
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer.
Yildiz Y; Kucukzeybek Y; Alacacioglu A; Varol U; Yildiz I; Akyol M; Kabadayι G; Taskaynatan H; Salman T; Bayoglu V; Oflazoglu U; Tarhan MO
Eur J Gynaecol Oncol; 2017; 38(3):444-448. PubMed ID: 29693888
[TBL] [Abstract] [Full Text] [Related]
18. Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
Yamashita Y; Akatsuka S; Shinjo K; Yatabe Y; Kobayashi H; Seko H; Kajiyama H; Kikkawa F; Takahashi T; Toyokuni S
PLoS One; 2013; 8(3):e57724. PubMed ID: 23469222
[TBL] [Abstract] [Full Text] [Related]
19. Survival impact of initial surgical approach in stage I ovarian cancer.
Wu TI; Lee CL; Liao PJ; Huang KG; Chang TC; Chou HH; Wang CJ; Soong YK; Hsueh S; Lai CH
Chang Gung Med J; 2010; 33(5):558-67. PubMed ID: 20979707
[TBL] [Abstract] [Full Text] [Related]
20. Potential target antigens for a universal vaccine in epithelial ovarian cancer.
Vermeij R; Daemen T; de Bock GH; de Graeff P; Leffers N; Lambeck A; ten Hoor KA; Hollema H; van der Zee AG; Nijman HW
Clin Dev Immunol; 2010; 2010():. PubMed ID: 20885926
[TBL] [Abstract] [Full Text] [Related]
[Next]
